Overall these findings highlight marked inflammation in HIV+ children and adolescents despite preserved CD4 T cells, which has been linked to poor long-term outcomes including impaired neurodevelopment, cardiovascular and metabolic disease, and HIV disease progression [30–32] and potential for normalization with treatment. Here, CD4 is linked to metabolic disease.